Previous Article | Next Article 
Journal of Clinical Microbiology, February 1999, p. 339-341, Vol. 37, No. 2
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Evaluation of a Colorimetric PCR-Based Assay To
Diagnose Plasmodium falciparum Malaria in
Travelers
Kathleen J. Y.
Zhong and
Kevin C.
Kain*
Tropical Disease Unit, Division of Infectious
Diseases, Department of Medicine, Toronto Hospital, and the
University of Toronto, Toronto, Ontario, Canada
Received 23 June 1998/Returned for modification 20 August
1998/Accepted 2 November 1998
 |
ABSTRACT |
New diagnostic tests are needed to facilitate the diagnosis of
Plasmodium falciparum malaria in the returned traveler. We performed a blinded evaluation of a nonisotopic colorimetric PCR-based assay (Digene SHARP Signal System) and compared the results with those
obtained by microscopy and nested PCR for the detection of P. falciparum malaria in 150 febrile travelers. By using nested PCR
as the reference standard, the colorimetric assay had a sensitivity of
100% and a specificity of 95.4% for the detection of P. falciparum. This PCR-based nonisotopic assay is a rapid,
sensitive, and specific method for the detection of falciparum malaria
in returned travelers.
 |
INTRODUCTION |
The diagnosis of malaria has
traditionally relied on the microscopic examination of
Giemsa-stained blood smears. This process is time-consuming and
labor-intensive, and accurate species identification is problematic in
patients with low levels of parasitemia or those with mixed
infections (1, 4, 5, 7, 11, 13). Alternative methods for the
diagnosis of malaria are required. PCR-based methods have been
demonstrated to be sensitive and specific for the detection of
Plasmodium falciparum and Plasmodium vivax
infections, with reported sensitivities approximately 10-fold
greater than that of microscopy performed by experts (4-6,
11-13). Amplified products are usually detected by
gel electrophoresis or by Southern or slot blotting followed by
hybridization with DNA probes (1, 4-6, 9, 11-13). These
approaches are often labor-intensive, require detection of
radioactivity, or are otherwise poorly suited for use in general
diagnostic laboratories. A nonisotopic, colorimetric PCR-based
system for the detection and quantitation of PCR products in a
microtiter format has been commercially developed (Digene SHARP Signal
System). This method involves hybridization of a single-stranded
RNA (ssRNA) probe to denatured biotinylated PCR products
and capture of the RNA-DNA hybrids on a streptavidin-coated microtiter plate, followed by colorimetric detection with an
enzyme-labeled antibody and a chromogenic substrate. We have previously
shown this to be a sensitive and specific method for the diagnosis of P. vivax malaria (3).
In the present study, we undertook an evaluation of a colorimetric
PCR-based assay for the diagnosis of P. falciparum
malaria in febrile travelers. The results of this assay
were compared with those of microscopic detection of P. falciparum and a nested PCR method for the diagnosis of
falciparum malaria.
 |
MATERIALS AND METHODS |
Patients presenting to the Tropical Disease Unit of the Toronto
Hospital from June 1995 to July 1997 with a history of fever and travel
to a area of endemicity for malaria were eligible for inclusion in this
prospective study. All patients with positive malaria smears during the
study period were enrolled. All patients with negative smears during
the first 2 months of the study were enrolled to provide a comparable
control group. The prevalence of malaria during the study period was
31%. Whole-blood samples (pretreatment) were collected from all
patients and placed into tubes with EDTA anticoagulant for thick and
thin malaria smears, PCR, and complete blood count. Blood smears were
interpreted by an expert microscopist who was unaware of the PCR
results. Blood films were called negative if no parasites were seen in
500 oil-immersion fields (magnification, ×1,000) on a thick blood
film. The parasite concentration was calculated by determining the
number of parasites per 200 to 500 leukocytes in a thick blood film.
The patients' baseline leukocyte counts were used to calculate the
level of parasitemia (numbers of parasites per microliter). Demographic data were collected by patient interview and medical chart review. All
specimens were coded, aliquoted, and frozen at
70°C for further testing by PCR. The colorimetric and nested PCR assays were run, and
the results were interpreted independently by an investigator who was
blinded to the results of microscopy. This study was approved by the
Ethical Review Committee of the Toronto Hospital.
The QIAamp blood kit (Qiagen, Chatsworth, Calif.) was used to extract
genomic DNA from 200-µl blood samples. For the Digene SHARP Signal
System colorimetric PCR-based assay, a 206-bp segment specific for
P. falciparum was amplified with 5 µl of extracted genomic
DNA and the K1-14 primer set, which included a biotinylated sense
primer, as described previously (6, 11). A 5-µl aliquot of
the PCR mixture containing the 5' biotinylated product was hybridized
with a K1-14 ssRNA probe. The resultant RNA-DNA hybrids were captured
through biotin on the surfaces of streptavidin-coated microwells.
Immobilized hybrids were then reacted with an antihybrid antibody
conjugated to alkaline phosphatase and were detected with a
colorimetric substrate. The absorbance at 405 nm was read after 2 and
20 h of substrate incubation. An absorbance reading of 0.1 was
used as the cutoff value, as recommended by the manufacturer. As an
independent confirmation of the species identification, a nested PCR
method for the amplification of a fragment of the plasmodial
small-subunit RNA gene was performed as described previously (12). The sensitivity and specificity of the Digene kit for the diagnosis of P. falciparum infection were calculated by
using nested PCR-based species identification as the reference
standard. We used PCR as the reference standard on the basis of its
reported superior performance characteristics over that of microscopy
(1, 3-7, 9-13). Sensitivity was calculated as numbers of
true positives/(numbers of true positives + numbers of false
negatives), and specificity was calculated as numbers of true
negatives/(numbers of true negatives + numbers of false
positives). Steps for the prevention cross-contamination were taken as
described previously (8).
 |
RESULTS |
During the study period, 150 patients presenting with fever and
travel to a area of endemicity for malaria were enrolled. The ratio of
male patients to female patients was 1.6:1, and the mean age was 38 years (age range, 20 months to 80 years). Travel destinations included
Africa (64.4%), the Indian subcontinent (16.1%), Latin America
(14%), Oceania (3.4%), and Southeast Asia (2.3%). Patients infected
with P. falciparum did not differ significantly from other
patients with respect to age, sex, or duration of illness. Only 5% of
travelers who acquired malaria were compliant with appropriate
chemoprophylaxis regimens (7).
The results of microscopic and nested PCR diagnosis of these infections
are presented in Table 1. On the basis of
repeatedly negative malaria smears and a negative PCR result, 24 travelers did not have malaria. Of the individuals with malaria, 39.7%
(50 of 126) had P. vivax infection, 50% (63 of 126)
had P. falciparum infection including 4 with mixed
falciparum infections, and 10.3% (13 of 126) had Plasmodium
ovale infection as determined by nested PCR. Complete or partial
concordance between the results of microscopy and those of nested PCR
was very good (98%). However, of the 52 patients with P. falciparum and mixed infections diagnosed by microscopy, nested
PCR could not confirm one case as falciparum malaria. Of 64 samples in
which non-falciparum malaria was diagnosed by microscopy, nested PCR
identified an additional 4 P. falciparum-positive samples, with 3 of the 4 having mixed infections. Of 10 samples in
which the level of parasitemia was too low for accurate species identification by microscopy, 8 were positive for P. falciparum by PCR. The results of the colorimetric assay in
comparison with those of nested PCR are presented in Table
2. By using the nested PCR result as the
reference standard, the colorimetric assay (with a 20-h substrate
incubation) detected P. falciparum in all 63 P. falciparum-positive samples, giving a sensitivity of
100%. For 87 patients either without malaria or with malaria caused by
a species other than P. falciparum, the colorimetric
assay was negative for 83 of the patients (specificity, 95.4%). With a
2-h substrate incubation, the sensitivity was 88% and the specificity was 98%. The level of parasitemia in patients with P. falciparum infections ranged from 20 to 125,300 parasites/µl
(mean, 23,860 parasites/µl). The correlation between the absorbance
reading and the level of parasitemia, as determined by microscopy, was poor (r = 0.3; data not shown).
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Results of colorimetric assay versus nested PCR for the
diagnosis of P. falciparum malaria in 150 febrile travelers
|
|
 |
DISCUSSION |
Microscopy is the traditional method for the diagnosis of malaria
caused by P. falciparum. However, accurate species
determination may be difficult to achieve in all patients. In this
study, as in others (1, 3-7, 10-13), diagnosis by
microscopy is problematic in patients with mixed infections and for
those with low levels of parasitemia. New molecular diagnostic tools
are needed for P. falciparum. In the present study, we
evaluated a new colorimetric PCR-based assay for the diagnosis of
P. falciparum malaria in nonimmune travelers. On the
basis of its previously demonstrated performance characteristics, we
chose a nested PCR-based method as the reference standard for
evaluation of this method. Compared to the reference method, the
colorimetric assay had a sensitivity of 100% and a specificity of
95.4% for the detection of P. falciparum infection.
All four false-positive samples were identified by nested PCR and
microscopy to be infected with P. vivax. It is possible
that these patients may have had mixed infections with P. falciparum at a level below that detectable by the nested PCR method. However, this seems less likely since these individuals did
not receive therapy considered effective against P. falciparum but did not subsequently develop falciparum malaria as
determined at a follow-up examination.
The colorimetric assay makes use of ssRNA probes which offer several
advantages: RNA-DNA hybrids have greater thermal stability than DNA-DNA
hybrids, allowing the use of higher temperatures with increased
stringency (2); sensitivity is increased since the increased
size of the ssRNA probes over the size of the oligonucleotide probes
results in stronger and more specific hybridization and permits the
incorporation of more label (14); RNA probes do not suffer
from competing hybridization events as is the case with double-stranded
DNA probes and therefore have increased rates of hybridization with the
target; detection and quantitation of a variety of targets are
possible; and the immunoassay-like system uses commercial reagents, a
microtiter format, and an enzyme-linked immunosorbent assay reader,
making it suitable for automation and for use in a routine diagnostic laboratory.
In conclusion, the colorimetric microtiter assay described here is a
simple and accurate method for the detection of P. falciparum. It may be particularly useful for the identification
of P. falciparum in patients with mixed infections or
in patients with low circulating levels of parasitemia, for whom
reliable species determination by microscopy is not always possible. A
limitation of this test is that only falciparum malaria is detected;
however, it may be combined with a similar assay for the diagnosis of
P. vivax malaria (3).
 |
ACKNOWLEDGMENTS |
This study was supported in part by the physicians of Ontario,
Canada, by a grant from The Physicians Services Incorporated. K.C.K.
was supported by a Career Scientist Award from the Ontario Ministry of Health.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Tropical Disease
Unit, EN G-224, The Toronto Hospital, 200 Elizabeth St., Toronto, Ontario M5G 2C4, Canada. Phone: (416) 340-3535. Fax: (416)
595-5826. E-mail: kkain{at}torhosp.toronto.on.ca.
 |
REFERENCES |
| 1.
|
Brown, A. E.,
K. C. Kain,
J. Pipithkul, and H. K. Webster.
1992.
Demonstration by the polymerase chain reaction of mixed Plasmodium falciparum and P. vivax infections undetected by conventional microscopy.
Trans. R. Soc. Trop. Med. Hyg.
86:609-612[Medline].
|
| 2.
|
Casey, J., and N. Davidson.
1977.
Rates of formation and thermal stabilities of RNA:DNA and DNA:DNA duplexes at high concentrations of formamide.
Nucleic Acids Res.
4:1539-1552[Abstract/Free Full Text].
|
| 3.
|
Humar, A.,
M. A. Harrington, and K. C. Kain.
1997.
Evaluation of a non-isotopic polymerase chain reaction-based assay to detect and predict treatment failure of Plasmodium vivax malaria in travelers.
Trans. R. Soc. Trop. Med. Hyg.
91:406-409[Medline].
|
| 4.
|
Humar, A.,
C. Ohrt,
M. A. Harrington,
D. Pillai, and K. C. Kain.
1997.
ParaSight®F test compared with the polymerase chain reaction and microscopy for the diagnosis of Plasmodium falciparum malaria in travelers.
Am. J. Trop. Med. Hyg.
55:44-48.
|
| 5.
|
Kain, K. C.,
A. E. Brown,
L. Mirabelli, and H. K. Webster.
1993.
Detection of Plasmodium vivax by polymerase chain reaction in a field study.
J. Infect. Dis.
168:1323-1326[Medline].
|
| 6.
|
Kain, K. C.,
D. E. Kyle,
C. Wongsrichanalai,
A. E. Brown,
H. K. Webster,
S. Vanijanonta, and S. Looareesuwan.
1994.
Qualitative and semiquantitative polymerase chain reaction to predict Plasmodium falciparum treatment failure.
J. Infect. Dis.
170:1626-1630[Medline].
|
| 7.
|
Kain, K. C.,
M. A. Harrington,
S. Tennyson, and J. S. Keystone.
1998.
Imported malaria: prospective analysis of problems in diagnosis and management.
Clin. Infect. Dis.
27:142-149[Medline].
|
| 8.
|
Kwok, S., and R. Higuchi.
1989.
Avoiding false positives with PCR.
Nature
339:237-238[Medline].
|
| 9.
|
Li, J.,
R. A. Wirtz,
G. A. McConkey,
J. Sattabongkot,
A. P. Waters,
M. J. Rogers, and T. F. McCutchan.
1995.
Plasmodium: genus-conserved primers for species identification and quantitation.
Exp. Parasitol.
81:182-190[Medline].
|
| 10.
|
Milne, L. M.,
M. S. Kyi, and P. L. Chiodini.
1994.
Accuracy of routine laboratory diagnosis of malaria in the United Kingdom.
J. Clin. Pathol.
47:740-742[Abstract/Free Full Text].
|
| 11.
|
Sethabutr, O.,
A. E. Brown,
S. Panyim,
K. C. Kain,
H. K. Webster, and P. Echeverria.
1992.
Detection of Plasmodium falciparum by polymerase chain reaction in a field study.
J. Infect. Dis.
166:145-148[Medline].
|
| 12.
|
Snounou, G.,
S. Viriyakosol,
X. P. Zhu,
W. Jarra,
L. Pinheiro,
V. E. do Rosario,
S. Thaithong, and K. N. Brown.
1993.
High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction.
Mol. Biochem. Parasitol.
61:315-320[Medline].
|
| 13.
|
Snounou, G.,
S. Viriyakosol,
W. Jarra,
S. Thaithong, and K. N. Brown.
1993.
Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of high prevalence of mixed infections.
Mol. Biochem. Parasitol.
58:283-292[Medline].
|
| 14.
|
Thompson, J. D., and D. Gillespie.
1990.
Current concepts in quantitative molecular hybridization.
Clin. Biochem.
23:261-266[Medline].
|
Journal of Clinical Microbiology, February 1999, p. 339-341, Vol. 37, No. 2
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Perandin, F., Manca, N., Calderaro, A., Piccolo, G., Galati, L., Ricci, L., Medici, M. C., Arcangeletti, M. C., Snounou, G., Dettori, G., Chezzi, C.
(2004). Development of a Real-Time PCR Assay for Detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for Routine Clinical Diagnosis. J. Clin. Microbiol.
42: 1214-1219
[Abstract]
[Full Text]
-
FARCAS, G. A., ZHONG, K. J. Y., LOVEGROVE, F. E., GRAHAM, C. M., KAIN, K. C.
(2003). EVALUATION OF THE BINAX NOW(R) ICT TEST VERSUS POLYMERASE CHAIN REACTION AND MICROSCOPY FOR THE DETECTION OF MALARIA IN RETURNED TRAVELERS. Am J Trop Med Hyg
69: 589-592
[Abstract]
[Full Text]
-
Ciach, M., Zong, K., Kain, K. C., Crandall, I.
(2003). Reversal of Mefloquine and Quinine Resistance in Plasmodium falciparum with NP30. Antimicrob. Agents Chemother.
47: 2393-2396
[Abstract]
[Full Text]
-
Morata, P., Queipo-Ortuno, M. I., Reguera, J. M., Garcia-Ordonez, M. A., Cardenas, A., Colmenero, J. D.
(2003). Development and Evaluation of a PCR-Enzyme-Linked Immunosorbent Assay for Diagnosis of Human Brucellosis. J. Clin. Microbiol.
41: 144-148
[Abstract]
[Full Text]
-
Richardson, D. C., Ciach, M., Zhong, K. J. Y., Crandall, I., Kain, K. C.
(2002). Evaluation of the Makromed Dipstick Assay versus PCR for Diagnosis of Plasmodium falciparum Malaria in Returned Travelers. J. Clin. Microbiol.
40: 4528-4530
[Abstract]
[Full Text]
-
Zhong, K. J. Y., Salas, C. J., Shafer, R., Gubanov, A., Gasser, R. A. Jr., Magill, A. J., Forney, J. R., Kain, K. C.
(2001). Comparison of IsoCode STIX and FTA Gene Guard Collection Matrices as Whole-Blood Storage and Processing Devices for Diagnosis of Malaria by PCR. J. Clin. Microbiol.
39: 1195-1196
[Abstract]
[Full Text]
-
Crandall, I., Charuk, J., Kain, K. C.
(2000). Nonylphenolethoxylates as Malarial Chloroquine Resistance Reversal Agents. Antimicrob. Agents Chemother.
44: 2431-2434
[Abstract]
[Full Text]
-
Louie, M., Louie, L., Simor, A. E.
(2000). The role of DNA amplification technology in the diagnosis of infectious diseases. CMAJ
163: 301-309
[Abstract]
[Full Text]